Antithrombin Iii Deficiency
📧 Sign up to get email alerts when something new happens for Antithrombin Iii Deficiency.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2019-07-02EMA Withdrawn: ATryn (antithrombin alfa) — Laboratoire Francais du Fractionnement et des Biotechnologies
The EMA withdrew ATryn (antithrombin alfa) from the market.
-
CLINICAL_TRIALS withdrawal · 2017-09-26Clinical Trial Update: Atenativ Effect on Uterine Blood Flow and Preeclampsia [Phase 4]
Phase 4 trial update for Atenativ assessing uterine blood flow and preeclampsia has been withdrawn.